Drug product development for highly potent APIs (HPAPIs) can be challenging. Complications with the interface between operations in drug substance and drug product handling can result in increased program complexity and cost. The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine. This year’s conference will focus on case studies related to development, rapid scaling, validation and commercial production of HPAPI drug substance, as well as integrated containment requirements for particle engineering and drug product.
FPS, Italian company specialized in the production of containment and micronization systems for Pharmaceutical, Biotech and Fine Chemical companies, is proud to announce the 2nd edition of Containment Workshop in partnership with MarketsandMarkets.
If you are already registered with us, please signup for the workshop here or you can register for the conferene here.
Head, Product Stewardship and Health, Takeda, Switzerland
Head Containment, SKAN AG, Switzerland
President, CEO, Affygility Soultions, USA
Quality Assurance Manager , Natrix Sciences, Malta
EHS Director , SK biotek Ireland
Product Manager Isolator Technology, Bosch
Managing Director , CTS Europe
EHS Director, BSP Pharmaceuticals, Italy
Head, CRAMS Sales , Dishman Europe Ltd.
Lead Process Engineer-Project & Engineering Manager, Process Service
Vice President, TAPI and BIO Global EHS, TEVA (TAPI and BIO division)
Director, Scientific Affairs, PCI Services, UK
Board Member, MarketsandMarkets
Managing Director , Bechter Consulting GmbH, Switzerland
Novotel Milano Linate Aeroporto Hotel, Milan, Italy